Turning skin into brain: Using patient‐derived cells to model X‐linked adrenoleukodystrophy
dc.contributor.author | Parent, Jack M. | en_US |
dc.date.accessioned | 2011-11-10T15:39:48Z | |
dc.date.available | 2012-11-02T18:56:54Z | en_US |
dc.date.issued | 2011-09 | en_US |
dc.identifier.citation | Parent, Jack M. (2011). "Turning skin into brain: Using patient‐derived cells to model X‐linked adrenoleukodystrophy." Annals of Neurology 70(3): 350-352. <http://hdl.handle.net/2027.42/87162> | en_US |
dc.identifier.issn | 0364-5134 | en_US |
dc.identifier.issn | 1531-8249 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/87162 | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.title | Turning skin into brain: Using patient‐derived cells to model X‐linked adrenoleukodystrophy | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Neurology University of Michigan Medical Center, Ann Arbor, MI | en_US |
dc.contributor.affiliationother | VA Ann Arbor Healthcare System, Ann Arbor, MI | en_US |
dc.identifier.pmid | 21905077 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/87162/1/22546_ftp.pdf | |
dc.identifier.doi | 10.1002/ana.22546 | en_US |
dc.identifier.source | Annals of Neurology | en_US |
dc.identifier.citedreference | Chamberlain SJ, Li XJ, Lalande M. Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics 2008; 9: 227 – 235. | en_US |
dc.identifier.citedreference | Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663 – 676. | en_US |
dc.identifier.citedreference | Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861 – 872. | en_US |
dc.identifier.citedreference | Yu J, Vodyanik MA, Smuga‐Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917 – 1920. | en_US |
dc.identifier.citedreference | Park IH, Arora N, Huo H, et al. Disease‐specific induced pluripotent stem cells. Cell 2008: 134; 877 – 886. | en_US |
dc.identifier.citedreference | Juopperi TA, Song H, Ming GL. Modeling neurological diseases using patient‐derived induced pluripotent stem cells. Future Neurol 2011; 6: 363 – 373. | en_US |
dc.identifier.citedreference | Bar‐Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage‐specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell 2011; 9: 17 – 23. | en_US |
dc.identifier.citedreference | Jozefczuk J, Prigione A, Chavez L, Adjaye J. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell‐derived hepatocyte‐like cells reveals current drawbacks and possible strategies for improved differentiation. Stem Cells Dev 2011; 20: 1259 – 1275. | en_US |
dc.identifier.citedreference | Chin MH, Mason MJ, Xie W, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5: 111 – 123. | en_US |
dc.identifier.citedreference | Doi A, Park IH, Wen B, et al. Differential methylation of tissue‐ and cancer‐specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009; 41: 1350 – 1353. | en_US |
dc.identifier.citedreference | Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949 – 953. | en_US |
dc.identifier.citedreference | Yu J, Smuga‐Otto K, Tian S, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797 – 801. | en_US |
dc.identifier.citedreference | Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4: 472 – 476. | en_US |
dc.identifier.citedreference | Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008; 322: 945 – 949. | en_US |
dc.identifier.citedreference | Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458: 766 – 770. | en_US |
dc.identifier.citedreference | Kaji K, Norrby K, Paca A, et al. Virus‐free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458: 771 – 775. | en_US |
dc.identifier.citedreference | Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7: 618 – 630. | en_US |
dc.identifier.citedreference | Vierbuchen T, Ostermeier A, Pang ZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010; 463: 1035 – 1041. | en_US |
dc.identifier.citedreference | Pfisterer U, Kirkeby A, Torper O, et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A 2011; 108: 10343 – 10348. | en_US |
dc.identifier.citedreference | Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321: 1218 – 1221. | en_US |
dc.identifier.citedreference | Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient‐derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136: 964 – 977. | en_US |
dc.identifier.citedreference | Lee G, Papapetrou EP, Kim H, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient‐specific iPSCs. Nature 2009; 461: 402 – 406. | en_US |
dc.identifier.citedreference | Chiang CH, Su Y, Wen Z, et al. Integration‐free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry 2011; 16: 358 – 360. | en_US |
dc.identifier.citedreference | Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011; 473: 221 – 225. | en_US |
dc.identifier.citedreference | Ebert AD, Yu J, Rose FF, Jr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277 – 280. | en_US |
dc.identifier.citedreference | Marchetto MC, Carromeu C, Acab A, et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010; 143: 527 – 539. | en_US |
dc.identifier.citedreference | Jang J, Kang HC, Kim HS, et al. Induced pluripotent stem cell models from X‐linked adrenoleukodystrophy patients. Ann Neurol 2011; 70: 402 – 409. | en_US |
dc.identifier.citedreference | Ferrer I, Aubourg P, Pujol A. General aspects and neuropathology of X‐linked adrenoleukodystrophy. Brain Pathol 2010; 20: 817 – 830. | en_US |
dc.identifier.citedreference | Mosser J, Douar AM, Sarde CO, et al. Putative X‐linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993; 361: 726 – 730. | en_US |
dc.identifier.citedreference | Berger J, Molzer B, Fae I, Bernheimer H. X‐linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem Biophys Res Commun 1994; 205: 1638 – 1643. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.